EUVIMEDEUVIMED entdecken
Open Access

Distinct Trajectories of Chemotherapy-Induced Peripheral Neuropathy in Lymphoma Survivors Treated With R-CHOP

Chih Jung Wu, Ya-Fang Ho, Li-Yuan Bai, Ching Feng Wu, Ting Ting Chen, Ya Jung Wang

Oncology Nursing Forum · 2025

DOI: 10.1188/25.onf.191-204 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology Nursing Forum, 2025. Verfasst von Chih Jung Wu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Chih Jung Wu. Hauptthemen laut MEDLINE: Peripheral Nervous System Diseases, Antineoplastic Combined Chemotherapy Protocols, Lymphoma, Survivors. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: To explore the trajectories of chemotherapy-induced peripheral neuropathy (CIPN) in lymphoma survivors and assess subdomains of CIPN in this population. SAMPLE & SETTING: 80 newly diagnosed lymphoma survivors treated with R-CHOP were enrolled. METHODS & VARIABLES: CIPN was assessed before chemotherapy (T1), after the first chemotherapy cycle (T2), after the fourth chemotherapy cycle (T3), after the completion of chemotherapy (T4), and 10 weeks post-treatment (T5). CIPN was measured using the Total Neuropathy Score clinical version and the MD Anderson Symptom Inventory. RESULTS: Patients were categorized into high and low CIPN groups based on CIPN changes over time. The high CIPN group was older and experienced significantly more severe sensory peripheral neuropathy from T1 to T5, with the most severe symptoms observed at T4, followed by T3 and T5. IMPLICATIONS FOR NURSING: Healthcare providers should closely monitor older patients, those with pretreatment peripheral neuropathy symptoms, and those exhibiting pronounced sensory neuropathy during treatment to provide timely and effective symptom management, reducing the impact of CIPN.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Peripheral Nervous System DiseasesAntineoplastic Combined Chemotherapy ProtocolsLymphomaSurvivorsHumansVincristineMaleDoxorubicinCyclophosphamidePrednisoneFemaleAgedMiddle AgedRituximabAntibodies, Monoclonal, Murine-DerivedAdultAged, 80 and over

Stichwörter der Autor:innen

chemotherapy-induced peripheral neuropathylymphomatrajectory modeling

Substanzen

VincristineDoxorubicinCyclophosphamidePrednisoneRituximabR-CHOP protocolAntibodies, Monoclonal, Murine-Derived

Autor:innen und Institutionen

  • Chih Jung Wu.
  • Ya-Fang Ho.
  • Li-Yuan Bai.
  • Ching Feng Wu.
  • Ting Ting Chen.
  • Ya Jung Wang.

Zitieren

APA

Jung Wu, C., Ho, Y. F., Bai, L. Y., Wu, C. F., Chen, T. T., & Wang, Y. J. (2025). Distinct Trajectories of Chemotherapy-Induced Peripheral Neuropathy in Lymphoma Survivors Treated With R-CHOP. Oncology Nursing Forum. https://doi.org/10.1188/25.onf.191-204

Vancouver

Jung Wu C, Ho YF, Bai LY, Wu CF, Chen TT, Wang YJ. Distinct Trajectories of Chemotherapy-Induced Peripheral Neuropathy in Lymphoma Survivors Treated With R-CHOP. Oncology Nursing Forum. 2025. doi:10.1188/25.onf.191-204

BibTeX
@article{JungWu2025,
  author = {Jung Wu, Chih and Ho, Ya-Fang and Bai, Li-Yuan and Wu, Ching Feng and Chen, Ting Ting and Wang, Ya Jung},
  title = {Distinct Trajectories of Chemotherapy-Induced Peripheral Neuropathy in Lymphoma Survivors Treated With R-CHOP},
  journal = {Oncology Nursing Forum},
  year = {2025},
  doi = {10.1188/25.onf.191-204}
}
Kostenlos starten →